Literature DB >> 20127228

Radiation protection of persons living close to patients with radioactive implants.

Theodor W Kaulich1,2, Michael Bamberg3.   

Abstract

BACKGROUND: Permanent interstitial brachytherapy is--in certain cases--a very successful therapeutic option, but application of radioactive implants always results in only gradually diminishing radiation exposure of persons in the patient's immediate surroundings.
MATERIAL AND METHODS: Using patients with clinically localized prostate cancer treated with iodine-125 ((125)I) or palladium-103 ((103)Pd) as an example, it is shown how a patient, if necessary or wished by him, can, by wearing commercially available X-ray protection shorts, reduce radiation exposure of family members in such a way that at a distance r from the patient a given dose per year is not exceeded.
RESULTS: The computational procedures necessary for the determination of the individual periods of wearing X-ray protection clothing are provided in the form of formulae and graphics. All considerations and calculations can also be applied to other radiotherapeutic interventions involving the use of (125)I, (103)Pd or other gamma-sources.
CONCLUSION: If necessary, a patient with permanent radioactive implants can reduce radiation exposure of family members by wearing special X-ray protection clothing for a limited period of time. This kind of radiation protection is very efficient and considerably simpler to accomplish than a reduction of exposure time or an increase of the distance between the patient and family members.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127228     DOI: 10.1007/s00066-010-2073-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  19 in total

1.  Radiation safety parameters following prostate brachytherapy.

Authors:  S Smathers; K Wallner; T Korssjoen; C Bergsagel; R H Hudson; S Sutlief; J Blasko
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

2.  Prostate Risk Index (PRIX) as a new method of risk classification for clinically localized prostate cancer.

Authors:  Yasuo Yoshioka; Takehiro Inoue
Journal:  Strahlenther Onkol       Date:  2007-09       Impact factor: 3.621

3.  Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple Fiducials.

Authors:  Frederick Marc Köhler; Judit Boda-Heggemann; Beate Küpper; Dirk Wolff; Hansjörg Wertz; Frank Lohr; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

4.  Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters.

Authors:  Hans Schiefer; Friedrich von Toggenburg; Wolf Seelentag; Ludwig Plasswilm; Gerhard Ries; Cornelius Lenggenhager; Hans-Peter Schmid; Thomas Leippold; Ladislav Prikler; Bernd Krusche; Jakob Roth; Daniel Engeler
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

5.  Radiation exposure after permanent prostate brachytherapy.

Authors:  Federica Cattani; Andrea Vavassori; Alfredo Polo; Elena Rondi; Raffaella Cambria; Roberto Orecchia; Giampiero Tosi
Journal:  Radiother Oncol       Date:  2006-03-27       Impact factor: 6.280

Review 6.  Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.

Authors: 
Journal:  Ann ICRP       Date:  2005

7.  Interstitial irradiation with stereotactically implanted I-125 seeds for the treatment of cerebral glioma.

Authors: 
Journal:  Crit Rev Neurosurg       Date:  1999-07-28

8.  Transperineal permanent seed implantation of "low-risk" prostate cancer: 5-year-experiences in 118 patients.

Authors:  Thomas Block; Heinz Czempiel; Frank Zimmermann
Journal:  Strahlenther Onkol       Date:  2006-11       Impact factor: 3.621

9.  A radiation badge survey for family members living with patients treated with a (103)Pd permanent breast seed implant.

Authors:  Brian M Keller; Jean-Philippe Pignol; Eileen Rakovitch; Raxa Sankreacha; Peter O'Brien
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-29       Impact factor: 7.038

10.  Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.

Authors:  Jean-Philippe Pignol; Eileen Rakovitch; Brian M Keller; Raxa Sankreacha; Carole Chartier
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-18       Impact factor: 7.038

View more
  5 in total

1.  Comparison of stereotactic brachytherapy (125 iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases.

Authors:  Maximilian I Ruge; Martin Kocher; Mohammad Maarouf; Christina Hamisch; Harald Treuer; Jürgen Voges; Volker Sturm
Journal:  Strahlenther Onkol       Date:  2010-12-22       Impact factor: 3.621

2.  Impact of learning curve and technical changes on dosimetry in low-dose brachytherapy for prostate cancer.

Authors:  E Le Fur; J P Malhaire; D Baverez; F Delage; M A Perrouin-Verbe; F Schlurmann; S Guerif; G Fournier; O Pradier; A Valeri
Journal:  Strahlenther Onkol       Date:  2012-11-11       Impact factor: 3.621

3.  Respiratory-induced prostate motion: characterization and quantification in dynamic MRI.

Authors:  Julien Dinkel; Christian Thieke; Christian Plathow; Patrick Zamecnik; Hermann Prüm; Peter E Huber; Hans-Ulrich Kauczor; Heinz-Peter Schlemmer; Christian M Zechmann
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

4.  A novel perineal shield for low-dose-rate prostate brachytherapy.

Authors:  Joseph P Weiner; David Schwartz; Joseph Safdieh; Alex Polubarov; Tejas Telivala; Matthew Worth; David Schreiber
Journal:  J Contemp Brachytherapy       Date:  2015-06-08

5.  A novel radiation-shielding undergarment using tungsten functional paper for patients with permanent prostate brachytherapy.

Authors:  Masahiro Inada; Hajime Monzen; Kenji Matsumoto; Mikoto Tamura; Takafumi Minami; Kiyoshi Nakamatsu; Yasumasa Nishimura
Journal:  J Radiat Res       Date:  2018-05-01       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.